Login / Signup

Effectiveness of the Booster of SARS-CoV-2 Vaccine among Japanese Adolescents: A Cohort Study.

Yoshika SaitoKana YamamotoMorihito TakitaMasahiro KamiMasaharu TsubokuraKenji Shibuya
Published in: Vaccines (2022)
Vaccination is effective in preventing COVID-19-related hospitalization among all age groups, but there is limited evidence on the effectiveness of the booster of the SARS-CoV-2 vaccine among adolescents. We analyzed the data on the status of SARS-CoV-2 infection and their vaccination profiles in adolescents aged 13-18 years in Soma city (Fukushima, Japan) ( n = 1835) from 14 May to 15 June 2022. The crude incidence rate and 95% confidence interval were calculated with the negative-binomial regression model after classifying the immunization status. The crude effectiveness of a booster administration to prevent infections was estimated as 86.4% (95% confidence interval: 57.2-95.7) when compared with the primary vaccination alone. The results of this study support that the community-based mass vaccination campaign of a booster dose among adolescents has additional protection from COVID-19 during the period of the B.1.1.529 (omicron) variant wave.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • randomized controlled trial
  • systematic review
  • young adults
  • coronavirus disease
  • physical activity
  • risk factors
  • electronic health record
  • machine learning